References
- Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, et al. ACC/AHA guidelines for coronary angiog raphy. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33:1756-824. DOI: 10.1016/S0735-1097(99)00126-6
- Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011; 123: 18-209 DOI: 10.1161/CIR.0b013e3182009701
- Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM. 2006; 56: 967-976.
- Eriksson EE, Xie X, Werr J, Thoren P, Lindbom L. Importance of primary capture and L-selectindependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med. 2001;194:205-18. DOI: 10.1084/jem.194.2.205
- Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A. 1995;92:8264-8. DOI: 10.1073/pnas.92.18.8264
- Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;92:3893-7. DOI: 10.1073/pnas.92.9.3893
- Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kaski JC. Angiographic stenosis progression and coronary events in patients with ‘stabilized’ unstable angina. Circulation. 1995;91:2319-24 DOI: 10.1161/01.CIR.91.9.2319
- Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-82 DOI: 10.1056/NEJM199705013361802
- Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Virmani R. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.Am J Cardiol. 2006 Jan 15;97 (2):175-80. DOI: 10.1016/j.amjcard.2005.08.020
- Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354: 1264-1272. DOI: 10.1056/NEJMoa054013
- Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, et al. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem. 2010; Jun;56(6):967-76. DOI: 10.1373/clinchem.2009.137489
- Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, et al. C-reative protein in the arterial intima: rol of C-reative protein receptor-dependent monocyte recruitment in atherogenenesis. Arterioscler Thromb Vase Biol. 2000; 20:2094-9. DOI: 10.1161/01.ATV.20.9.2094
- Oei H-H S, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MMB, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke. The Rotterdam Study. Circulation. 2005;111:570-575. DOI: 10.1161/01.CIR.0000154553.12214.CD
- Stafforini DM, McIntyre TM, Carter ME, Prescott SM. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degredation of platelet-activating factor. J Biol Chem. 1987;262:4215-4222. DOI: 10.1016/S0021-9258(18)61335-3
- Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD, et al. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma. Clin Chem. 2005;51: 2264-2273. DOI: 10.1373/clinchem.2005.058404
- Persson M, Nilsson J-A, Nelson JJ, Berglund G. The epidemiology of Lp-PLA2: distribution and correlation with cardiovascular risk factors in a population-based cohort. Atherosclerosis. 2007;190:388-396 DOI: 10.1016/j.atherosclerosis.2006.02.016
- Budoff MJ, Achenbach S, Duerinckx A. Clinical utility of computed tomography and magnetic resonance techniques for noninvasive coronary angiography. J Am Coll Cardiol. 2003; 42:1867-78. DOI: 10.1016/j.jacc.2003.07.018
- Achenbach S, Ropers D, Hoffmann U. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol. 2004; 43: 842-7. DOI: 10.1016/j.jacc.2003.09.053
- White CS, Kuo D. Chest pain in the emergency department: role of multidetector CT. Radiology. 2007; 245: 672-81. DOI: 10.1148/radiol.2453061481
- Schuijf JD, Jukema JW, van der Wall EE, Bax JJ. Multi-slice computed tomography in the evaluation of patients with acute chest pain. Acute Card Care. 2007; 9: 214-21. DOI: 10.1080/17482940701589275
- Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999; 138 (52): 19-20. DOI: 10.1016/S0002-8703(99)70266-8
- Koenig W, Löwel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the framingham score : ımplications for future risk assessment: results from a large cohort study in Southern Germany. Circulation. 2004;109:1349-1353. DOI: 10.1161/01.CIR.0000120707.98922.E3
- Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2006; 26:2523-2529. DOI: 10.1161/01.ATV.0000244681.72738.bc
- Schoenhagen P, McErlean ES, Nissen SE. The vulnerable coronary plaque. J Cardiovasc Nurs. 2000 Oct;15(1):1-12. DOI: 10.1097/00005082-200010000-00002
- Nishikura T, Koba S, Yokota Y, Hirano T, Tsunoda F, Shoji M, et al. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery diseaseJ Atheroscler Thromb. 2014;21 (8):755-67. DOI: 10.5551/jat.23465
- Kunutsor SK, Zaccardi F, Karppi J, Kurl S, Laukkanen JA. Is High Serum LDL/HDL Cholesterol Ratio an Emerging Risk Factor for Sudden Cardiac Death. Findings from the KIHD Study J Atheroscler Thromb. 2017 Jun 1;24 (6):600-608. DOI: 10.5551/jat.37184
- Moriyama K, Takahashi E. Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDLCholesterol in Japanese Subjects with TG Levels <400 mg/dL. J Atheroscler Thromb. 2016 Sep 1;23 (9):1126-37. DOI: 10.5551/jat.33985
- Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF. Cardiovascular events with increased lipoprotein-associated phospholipase A (2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.Arterioscler Thromb Vasc Biol. 2008 Jun;28 (6):1172-8. DOI: 10.1161/ATVBAHA.107.160739
- Corson MA, Jones PH, Davidson MH. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Am J Cardiol. 2008;101:51-50. DOI: 10.1016/j.amjcard.2008.04.018
- Lerman A, McConnell JP. Lipoprotein-associated phospholipase A2: A risk marker or a risk factor? Am J Cardiol. 2008;101:11-22. DOI: 10.1016/j.amjcard.2008.04.014
- Ferri N, Paoletti R, Corsini A. Lipid-modified proteins as biomarkers for cardiovascular disease: a review. Biomarkers. 2005 Jul-Aug;10 (4):219-37. DOI: 10.1080/13547500500216660
- Segers D, Helderman F, Cheng C, van Damme LC, Tempel D, Boersma E, et al. Gelatinolytic activity in atherosclerotic plaques is highly localized and is associated with both macrophages and smooth muscle cells in vivo. Circulation. 2007;115:609-16. DOI: 10.1161/CIRCULATIONAHA.106.636415
- Chen Y, Fu Y, Wang S, Chen P, Pei Y, Zhang J, et al. Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years. Cardiovasc Diabetol. 2022 Nov 17;21(1):252. DOI: 10.1186/s12933-022-01668-5
- Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 Jan 28;107(3):499-511. DOI: 10.1161/01.CIR.0000052939.59093.45
- Liu H, Yao Y, Wang Y, Ji L, Zhu K, Hu H. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study. J Cell Mol Med. 2018 Oct;22(10):5145-5150. DOI: 10.1111/jcmm.13803
- Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta. 2006; 1761: 1246-59 DOI: 10.1016/j.bbalip.2006.07.011
- Daniels LB, Laughlin GA, Mark J, Bettencourt R, Wolfert RL, Barrett-Connor E. Lipoprotein -associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apperently healthy older populatıon: the Rancho Bernardo study. J Am Coll Cardiol. 2008; 51: 913-919. DOI: 10.1016/j.jacc.2007.10.048
- Hyemoon C, Hyuck Moon K, Jong-Youn K, Young Won Y, Rhee J, Choi EY, et al.Lipoprotein-Associated Phospholipase A2 Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome. Yonsei Med J 55(6):1507-1515, 2014. DOI: 10.3349/ymj.2014.55.6.1507
- Maiolino G, Bisogni V, Rossitto G, Rossi GP. Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications.World J Cardiol. 2015 Oct 26;7 (10):609-20. DOI: 10.4330/wjc.v7.i10.609
- Tooran A, Soudabeh F, Toktam Kazemi F, Reza F, Rahim R, Movahedi M, et al. Evaluation of MMP-9, IL-6, TNF-α levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease. Cardiovasc Thorac Res. 2023, 15(4), 223-230. DOI: 10.34172/jcvtr.2023.31844
- Liu B, Su L, Loo SJ, Gao Y, Khin E, Kong X, et al. Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes. Front Endocrinol (Lausanne). 2024 Apr 10;15:1369369. DOI: 10.3389/fendo.2024.1369369.